Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Journal of Virology|December 7, 2007
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trialAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
Cancers|March 6, 2021
The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell FeaturesChiara Romani, Davide Capoferri, Elisabetta Grillo, et al.
Gynecologic Oncology|May 27, 2006
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapyEliana Bignotti, Renata A Tassi, Stefano Calza, et al.
Cancer|February 28, 2007
Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE)Alessandro D Santin, Stefania Bellone, Moira Marizzoni, et al.
Gynecologic Oncology|October 27, 2005
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalitiesAlessandro D Santin, Stefania Bellone, Michela Palmieri, et al.
Gynecologic Oncology|April 2, 2011
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibodyJoyce Varughese, Emiliano Cocco, Stefania Bellone, et al.
Gynecologic Oncology|June 2, 2007
Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: implications for Cetuximab-mediated therapy in recurrent/metastatic diseaseStefania Bellone, Gianluca Frera, Gianpiero Landolfi, et al.
International Journal of Surgery (London, England)|August 25, 2014
Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic OncologyStefano Greggi, Massimo Franchi, Giovanni Aletti, et al.
American Journal of Obstetrics and Gynecology|July 30, 2013
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2)Diana P English, Stefania Bellone, Emiliano Cocco, et al.
Cancer|January 20, 2011
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibodyJoyce Varughese, Emiliano Cocco, Stefania Bellone, et al.
Pageof 19